A consistently observed effect of the frataxin deficit in FRDA patients, FRDA mouse models and yeast models is a reduction in activity of the iron–sulfur cluster containing enzyme aconitase (Bradley et al., 2000; Puccio et al., 2001; Rotig et al., 1997). Here, FXN is linked to Friedreich ataxia.